Column

Healthy people who develop serious complications following infection with respiratory viruses, such as influenza, respiratory syncytial virus (RSV) or COVID, produce very high amounts of an enzymatic protein involved in lipid metabolism: an intriguing biochemical discovery, which could allow rapid identification of high-risk patients and improve their survival rate. Download the column